Platelet--cancer interactions: mechanisms and pharmacology of tumour cell-induced platelet aggregation.
about
Minimal residual disease in breast cancer: an overview of circulating and disseminated tumour cellsTumor-Associated Macrophages and Neutrophils in Tumor MicroenvironmentNovel insights into the regulation of cyclooxygenase-2 expression by platelet-cancer cell cross-talkTumor-platelet interaction in solid tumorsElectron cryotomography reveals ultrastructure alterations in platelets from patients with ovarian cancerEnhanced platelet activation mediates the accelerated angiogenic switch in mice lacking histidine-rich glycoproteinEmerging targets in lipid-based therapyVicrostatin - an anti-invasive multi-integrin targeting chimeric disintegrin with tumor anti-angiogenic and pro-apoptotic activitiesPaper wasp nest-mediated biosynthesis of silver nanoparticles for antimicrobial, catalytic, anticoagulant, and thrombolytic applicationsMicroenvironmental regulation of metastasisPhotoacoustic flow cytometryDifferential inhibition of tumour cell-induced platelet aggregation by the nicotinate aspirin prodrug (ST0702) and aspirin.Elucidation of flow-mediated tumour cell-induced platelet aggregation using an ultrasound standing wave trap.Three-dimensional chemotaxis-driven aggregation of tumor cells.Living in shear: platelets protect cancer cells from shear induced damage.Targeted downregulation of platelet CLEC-2 occurs through Syk-independent internalization.Shen-Cao granules formulated based on traditional Chinese medicine alleviates bone marrow suppression caused by platinum-based anticancer reagents.Platelet activation in the postoperative period after lung transplantation.Thrombospondin 1 expression and angiogenesis in breast carcinoma and their relation with platelet activity.Platelet-derived thrombospondin-1 is a critical negative regulator and potential biomarker of angiogenesis.P-selectin-mediated platelet activation promotes adhesion of non-small cell lung carcinoma cells on vascular endothelial cells under flowPlatelets and cancer: a casual or causal relationship: revisited.Correlation between bone metastasis and thrombocytosis in pulmonary adenocarcinoma patients.Characterization of aberrant pathways across human cancersDevelopment of a chimeric recombinant disintegrin as a cost-effective anti-cancer agent with promising translational potential.Aspirin and P2Y12 inhibition attenuate platelet-induced ovarian cancer cell invasion.Effects of celecoxib on prostanoid biosynthesis and circulating angiogenesis proteins in familial adenomatous polyposis.Platelets and metastasis revisited: a novel fatty link.Chemically modified heparins inhibit fibrinogen-bridged indirect adhesion between tumor cells and plateletsThe Tumor-immune Index is Correlated With the Prognosis of Patients After Curative Resection for Nonsmall Cell Lung Cancer.Thrombospondin-1 stimulates platelet aggregation by blocking the antithrombotic activity of nitric oxide/cGMP signaling.Tissue factor-positive tumor microvesicles activate platelets and enhance thrombosis in mice.Prognostic significance of the combination of preoperative hemoglobin, albumin, lymphocyte and platelet in patients with gastric carcinoma: a retrospective cohort study.Identification of a novel platelet antagonist that binds to CLEC-2 and suppresses podoplanin-induced platelet aggregation and cancer metastasisPlatelets increase survival of adenocarcinoma cells challenged with anticancer drugs: mechanisms and implications for chemoresistance.Phosphatidylserine exposing-platelets and microparticles promote procoagulant activity in colon cancer patients.A platelet-mimetic paradigm for metastasis-targeted nanomedicine platformsThe metastasis-promoting roles of tumor-associated immune cellsAnticancer Platelet-Mimicking Nanovehicles.Low-dose aspirin use and cancer characteristics: a population-based cohort study.
P2860
Q26748850-A9667297-C617-4993-884E-8201460F0AA4Q26766429-DD679461-9DDB-4509-8676-C0C3B3513DB8Q26778352-71ABFD20-6975-4CDF-B265-588B5029CB04Q26853099-55FD17D6-D893-4A20-8BF4-58F51BF35E5CQ27318101-A93DBAAF-2290-464C-9947-1BA075521318Q28586472-C3BFFA7E-90EB-4670-903F-548046F6FDB1Q28655456-C2EA3080-5170-4103-8492-7F8C874340FCQ28751757-28A55982-3235-4E6F-AAB9-97A3977555C4Q28829346-F2F1BAD3-9A0E-4165-A6D8-319FD2B51A06Q29547660-7FF4FBFF-DC45-41E6-802E-5E4007AA5057Q30388093-3A1E3971-0239-4016-AA1B-E0DE395D7B64Q30453962-394BE3E2-7131-48AC-9C76-25DFB583B125Q30468939-1718DA5D-B446-4725-8B85-4E36D69ABF84Q30668765-41EADF83-E5E9-46C2-A689-133070641DDCQ33415986-76E0830E-0A4D-499F-B3C2-0303DB985E65Q33421358-1F4D46FB-8D5F-4F6B-96FA-8FF0E56E38E7Q33441730-57F199B2-F2E2-4164-906D-200D108C82ECQ33691702-D6CE5D5E-86C8-47F0-8270-DB646F7CA450Q33781816-AB6BD598-048C-499B-956F-98F92AA4E235Q33896683-DFD2EEB4-544A-4212-A678-94035342D69CQ34135244-A302F6CA-05C5-4692-86C2-9878FD52C04EQ34294719-D0087E5F-4A05-416F-B825-C5F19A43A216Q34993775-05E0C132-EFD5-4E26-B867-9C37B4E2DF62Q35051387-1C347754-CA20-49B9-B8F2-D54111699D6FQ35089514-AA552ABF-4DC8-4BCE-9CED-6EF122EC96FAQ35768450-CEED1107-C2EE-48C1-B47B-2899CE38506BQ35847666-DD91F26A-AB0E-4BD8-979F-A7284E8EBCE2Q35984309-31C935DE-487F-4348-B664-A63F8DC41429Q35995399-377CB5F0-17D7-412B-8BFE-8DA0ECBB7F81Q36359123-B629CF7F-F446-4E69-ACB2-3F7B14160E65Q36384766-FD14D0C6-F690-4F53-BE1A-115AB89A0020Q36470049-F20C37E6-9798-4AA1-8E61-D99D8A0622ACQ36562386-7B91F2AA-ECF2-4FA7-A333-8D7059E35E57Q36618989-2C50769E-326D-40EE-AE8E-741473B33CB3Q36619756-90B603AA-4D3F-44B1-A104-813B49609DDEQ36728170-B9F1B76F-8B3A-41E3-88DC-1CA752D42559Q36949458-F92B4888-F15E-47CF-95BB-EE76558035EEQ36972016-4E6CF714-4079-45FF-9E23-0EFF46E31DB6Q37206537-3A63A120-1151-4624-87BA-EF733B3B8BEBQ37214225-6474AC3D-9444-4ED7-86B3-4B69459D8889
P2860
Platelet--cancer interactions: mechanisms and pharmacology of tumour cell-induced platelet aggregation.
description
2004 nî lūn-bûn
@nan
2004 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Platelet--cancer interactions: ...... -induced platelet aggregation.
@en
type
label
Platelet--cancer interactions: ...... -induced platelet aggregation.
@en
prefLabel
Platelet--cancer interactions: ...... -induced platelet aggregation.
@en
P2093
P2860
P356
P1476
Platelet--cancer interactions: ...... -induced platelet aggregation.
@en
P2093
David Alonso-Escolano
Marek W Radomski
Paul Jurasz
P2860
P304
P356
10.1038/SJ.BJP.0706013
P407
P577
2004-10-18T00:00:00Z